As of 2024-12-12, the Fair Value of Codiak BioSciences, Inc. (CDAK) is -9.30 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.06 USD, the upside of Codiak BioSciences, Inc. is -16,415.50%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | - | - | 5Y Avg | |
| Net income | -91.67 | -37.16 | - | - | -64.41 | |
| YoY growth | -17.58% | 59.46% | - | - | 20.94% | |
| Market Cap (mil) | 4.77 |
| P/E | |
| Forward P/E |
| EPS | -0.44 |
| Avg earnings growth rate | 20.94% |
| TTM earnings | -37.16 |